BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22084393)

  • 1. IgG from patients with pulmonary arterial hypertension and/or systemic sclerosis binds to vascular smooth muscle cells and induces cell contraction.
    Bussone G; Tamby MC; Calzas C; Kherbeck N; Sahbatou Y; Sanson C; Ghazal K; Dib H; Weksler BB; Broussard C; Verrecchia F; Yaici A; Witko-Sarsat V; Simonneau G; Guillevin L; Humbert M; Mouthon L
    Ann Rheum Dis; 2012 Apr; 71(4):596-605. PubMed ID: 22084393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of target antigens of antifibroblast antibodies in pulmonary arterial hypertension.
    Terrier B; Tamby MC; Camoin L; Guilpain P; Broussard C; Bussone G; Yaïci A; Hotellier F; Simonneau G; Guillevin L; Humbert M; Mouthon L
    Am J Respir Crit Care Med; 2008 May; 177(10):1128-34. PubMed ID: 18276943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension.
    Tamby MC; Chanseaud Y; Humbert M; Fermanian J; Guilpain P; Garcia-de-la-Peña-Lefebvre P; Brunet S; Servettaz A; Weill B; Simonneau G; Guillevin L; Boissier MC; Mouthon L
    Thorax; 2005 Sep; 60(9):765-72. PubMed ID: 16135682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targets of anti-endothelial cell antibodies in pulmonary hypertension and scleroderma.
    Dib H; Tamby MC; Bussone G; Regent A; Berezné A; Lafine C; Broussard C; Simonneau G; Guillevin L; Witko-Sarsat V; Humbert M; Mouthon L
    Eur Respir J; 2012 Jun; 39(6):1405-14. PubMed ID: 22005913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to fibroblasts in idiopathic and scleroderma-associated pulmonary hypertension.
    Tamby MC; Humbert M; Guilpain P; Servettaz A; Dupin N; Christner JJ; Simonneau G; Fermanian J; Weill B; Guillevin L; Mouthon L
    Eur Respir J; 2006 Oct; 28(4):799-807. PubMed ID: 16774952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifibroblast antibodies from systemic sclerosis patients bind to {alpha}-enolase and are associated with interstitial lung disease.
    Terrier B; Tamby MC; Camoin L; Guilpain P; Bérezné A; Tamas N; Broussard C; Hotellier F; Humbert M; Simonneau G; Guillevin L; Mouthon L
    Ann Rheum Dis; 2010 Feb; 69(2):428-33. PubMed ID: 19293162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nailfold capillary density is associated with the presence and severity of pulmonary arterial hypertension in systemic sclerosis.
    Hofstee HM; Vonk Noordegraaf A; Voskuyl AE; Dijkmans BA; Postmus PE; Smulders YM; Serné EH
    Ann Rheum Dis; 2009 Feb; 68(2):191-5. PubMed ID: 18375538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary arterial hypertension and severe pulmonary fibrosis in systemic sclerosis patients with a nucleolar antibody.
    Steen VD; Lucas M; Fertig N; Medsger TA
    J Rheumatol; 2007 Nov; 34(11):2230-5. PubMed ID: 17937469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis.
    Becker MO; Kill A; Kutsche M; Guenther J; Rose A; Tabeling C; Witzenrath M; Kühl AA; Heidecke H; Ghofrani HA; Tiede H; Schermuly RT; Nickel N; Hoeper MM; Lukitsch I; Gollasch M; Kuebler WM; Bock S; Burmester GR; Dragun D; Riemekasten G
    Am J Respir Crit Care Med; 2014 Oct; 190(7):808-17. PubMed ID: 25181620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral arterial stiffness and endothelial dysfunction in idiopathic and scleroderma associated pulmonary arterial hypertension.
    Peled N; Shitrit D; Fox BD; Shlomi D; Amital A; Bendayan D; Kramer MR
    J Rheumatol; 2009 May; 36(5):970-5. PubMed ID: 19369472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiendothelial cell antibodies in scleroderma correlate with severe digital ischemia and pulmonary arterial hypertension.
    Negi VS; Tripathy NK; Misra R; Nityanand S
    J Rheumatol; 1998 Mar; 25(3):462-6. PubMed ID: 9517764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pulmonary arterial hypertension quality enhancement research initiative: comparison of patients with idiopathic PAH to patients with systemic sclerosis-associated PAH.
    Clements PJ; Tan M; McLaughlin VV; Oudiz RJ; Tapson VF; Channick RN; Rubin LJ; Langer A;
    Ann Rheum Dis; 2012 Feb; 71(2):249-52. PubMed ID: 21998119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional implications of IgG anti-endothelial cell antibodies in pulmonary arterial hypertension.
    Arends SJ; Damoiseaux JG; Duijvestijn AM; Debrus-Palmans L; Boomars KA; Brunner-La Rocca HP; Cohen Tervaert JW; van Paassen P
    Autoimmunity; 2013 Nov; 46(7):463-70. PubMed ID: 24083390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased plasma soluble CD40 ligand concentrations in systemic sclerosis and association with pulmonary arterial hypertension and digital ulcers.
    Allanore Y; Borderie D; Meune C; Lemaréchal H; Weber S; Ekindjian OG; Kahan A
    Ann Rheum Dis; 2005 Mar; 64(3):481-3. PubMed ID: 15708899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis.
    Baroni SS; Santillo M; Bevilacqua F; Luchetti M; Spadoni T; Mancini M; Fraticelli P; Sambo P; Funaro A; Kazlauskas A; Avvedimento EV; Gabrielli A
    N Engl J Med; 2006 Jun; 354(25):2667-76. PubMed ID: 16790699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.
    Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H
    Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-fibroblast antibodies detected by cell-based ELISA in systemic sclerosis enhance the collagenolytic activity and matrix metalloproteinase-1 production in dermal fibroblasts.
    Fineschi S; Cozzi F; Burger D; Dayer JM; Meroni PL; Chizzolini C
    Rheumatology (Oxford); 2007 Dec; 46(12):1779-85. PubMed ID: 17982166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor for activated C-kinase 1, a novel interaction partner of type II bone morphogenetic protein receptor, regulates smooth muscle cell proliferation in pulmonary arterial hypertension.
    Zakrzewicz A; Hecker M; Marsh LM; Kwapiszewska G; Nejman B; Long L; Seeger W; Schermuly RT; Morrell NW; Morty RE; Eickelberg O
    Circulation; 2007 Jun; 115(23):2957-68. PubMed ID: 17515463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies against B23, a nucleolar phosphoprotein, occur in scleroderma and are associated with pulmonary hypertension.
    Ulanet DB; Wigley FM; Gelber AC; Rosen A
    Arthritis Rheum; 2003 Feb; 49(1):85-92. PubMed ID: 12579598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin G anti-endothelial cell antibodies: inducers of endothelial cell apoptosis in pulmonary arterial hypertension?
    Arends SJ; Damoiseaux JG; Duijvestijn AM; Debrus-Palmans L; Vroomen M; Boomars KA; Brunner-La Rocca HP; Reutelingsperger CP; Cohen Tervaert JW; van Paassen P
    Clin Exp Immunol; 2013 Dec; 174(3):433-40. PubMed ID: 23815467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.